{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-065828","form_type":"8-K","ticker":"RAPH","cik":"0001415397","company_name":"Raphael Pharmaceutical Inc.","filed_at":"2022-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.570421+00:00","generated_at":"2026-06-23T01:36:40.031467+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Raphael Pharmaceutical accepted for OTCQB up-list, to trade under 'RAPH'","bullets":["Application submitted September 1, 2022; notified of acceptance on October 7, 2022.","Will trade on OTCQB under ticker symbol 'RAPH' after trading approval from OTC Markets.","Company has paid required fees and increased financial transparency to meet OTCQB standards.","Management believes the up-list better positions the company for a greater growth trajectory."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-065828","json":"https://secwatch.observer/filing/0001213900-22-065828.json","markdown":"https://secwatch.observer/filing/0001213900-22-065828.md","text":"https://secwatch.observer/filing/0001213900-22-065828.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1415397/000121390022065828/0001213900-22-065828-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1415397/000121390022065828/ea167503-8k_raphael.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T01:36:40.031467+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}